As of Feb 17
| -0.02 / -3.77%|
The 5 analysts offering 12-month price forecasts for TearLab Corp have a median target of 2.00, with a high estimate of 3.00 and a low estimate of 0.70. The median estimate represents a +292.16% increase from the last price of 0.51.
The current consensus among 5 polled investment analysts is to Buy stock in TearLab Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.